Cargando…

Reproductive factors and hormone receptor status among very young (<35 years) breast cancer patients

The prognosis for breast cancer occurs in young women is usually poor. The impact of different reproductive factors on disease characteristics is still largely unknown. We analyzed 261 patients aged ≤35 years old who were treated at the Cancer Hospital of Fudan University, Shanghai, China. The relat...

Descripción completa

Detalles Bibliográficos
Autores principales: Jia, Xiaoqing, Liu, Guangyu, Mo, Miao, Cheng, Jingyi, Shen, Zhenzhou, Shao, Zhimin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695207/
https://www.ncbi.nlm.nih.gov/pubmed/26304928
_version_ 1782407621343444992
author Jia, Xiaoqing
Liu, Guangyu
Mo, Miao
Cheng, Jingyi
Shen, Zhenzhou
Shao, Zhimin
author_facet Jia, Xiaoqing
Liu, Guangyu
Mo, Miao
Cheng, Jingyi
Shen, Zhenzhou
Shao, Zhimin
author_sort Jia, Xiaoqing
collection PubMed
description The prognosis for breast cancer occurs in young women is usually poor. The impact of different reproductive factors on disease characteristics is still largely unknown. We analyzed 261 patients aged ≤35 years old who were treated at the Cancer Hospital of Fudan University, Shanghai, China. The relationships between certain reproductive factors (age at menarche, parity, number of children, breastfeeding, history of abortion, age at first full-term pregnancy and oral contraceptive (OC) use) and disease characteristics were evaluated. Compared with patients who experienced fewer full-term pregnancies (<2 times), the patients with more full-term pregnancies (≥2 times) exhibited higher percentage of ER-positive tumors (61.5%) (P = 0.015), and patients whose age of menarche was ≥15 years exhibited a greater chance of PR-positive tumors (64.8%) (P = 0.036) compared with those whose age of menarche was <15 years old. Additionally, patients who had taken OCs were more likely to present with late-stage tumors (II stage or later) (87.5%) (P = 0.002) than patients who had never taken OCs. Our study provides evidence that women with more full-term pregnancies and later age at menarche are more possible to exhibit hormone receptor-positive tumors. Additionally, patients who have taken OCs are more likely to present with advanced disease.
format Online
Article
Text
id pubmed-4695207
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-46952072016-01-26 Reproductive factors and hormone receptor status among very young (<35 years) breast cancer patients Jia, Xiaoqing Liu, Guangyu Mo, Miao Cheng, Jingyi Shen, Zhenzhou Shao, Zhimin Oncotarget Clinical Research Paper The prognosis for breast cancer occurs in young women is usually poor. The impact of different reproductive factors on disease characteristics is still largely unknown. We analyzed 261 patients aged ≤35 years old who were treated at the Cancer Hospital of Fudan University, Shanghai, China. The relationships between certain reproductive factors (age at menarche, parity, number of children, breastfeeding, history of abortion, age at first full-term pregnancy and oral contraceptive (OC) use) and disease characteristics were evaluated. Compared with patients who experienced fewer full-term pregnancies (<2 times), the patients with more full-term pregnancies (≥2 times) exhibited higher percentage of ER-positive tumors (61.5%) (P = 0.015), and patients whose age of menarche was ≥15 years exhibited a greater chance of PR-positive tumors (64.8%) (P = 0.036) compared with those whose age of menarche was <15 years old. Additionally, patients who had taken OCs were more likely to present with late-stage tumors (II stage or later) (87.5%) (P = 0.002) than patients who had never taken OCs. Our study provides evidence that women with more full-term pregnancies and later age at menarche are more possible to exhibit hormone receptor-positive tumors. Additionally, patients who have taken OCs are more likely to present with advanced disease. Impact Journals LLC 2015-07-01 /pmc/articles/PMC4695207/ /pubmed/26304928 Text en Copyright: © 2015 Jia et al. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Clinical Research Paper
Jia, Xiaoqing
Liu, Guangyu
Mo, Miao
Cheng, Jingyi
Shen, Zhenzhou
Shao, Zhimin
Reproductive factors and hormone receptor status among very young (<35 years) breast cancer patients
title Reproductive factors and hormone receptor status among very young (<35 years) breast cancer patients
title_full Reproductive factors and hormone receptor status among very young (<35 years) breast cancer patients
title_fullStr Reproductive factors and hormone receptor status among very young (<35 years) breast cancer patients
title_full_unstemmed Reproductive factors and hormone receptor status among very young (<35 years) breast cancer patients
title_short Reproductive factors and hormone receptor status among very young (<35 years) breast cancer patients
title_sort reproductive factors and hormone receptor status among very young (<35 years) breast cancer patients
topic Clinical Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695207/
https://www.ncbi.nlm.nih.gov/pubmed/26304928
work_keys_str_mv AT jiaxiaoqing reproductivefactorsandhormonereceptorstatusamongveryyoung35yearsbreastcancerpatients
AT liuguangyu reproductivefactorsandhormonereceptorstatusamongveryyoung35yearsbreastcancerpatients
AT momiao reproductivefactorsandhormonereceptorstatusamongveryyoung35yearsbreastcancerpatients
AT chengjingyi reproductivefactorsandhormonereceptorstatusamongveryyoung35yearsbreastcancerpatients
AT shenzhenzhou reproductivefactorsandhormonereceptorstatusamongveryyoung35yearsbreastcancerpatients
AT shaozhimin reproductivefactorsandhormonereceptorstatusamongveryyoung35yearsbreastcancerpatients